US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.085
  • -0.025-2.25%
Close Apr 28 16:00 ET
  • 1.085
  • 0.0000.00%
Post 20:01 ET
6.69MMarket Cap-0.62P/E (TTM)

Aytu BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
-13.48%16.22M
-6.98%16.57M
-24.58%81M
-41.51%17.98M
-20.85%17.99M
-28.66%18.75M
-35.57%17.82M
11.10%107.4M
11.96%30.73M
-6.06%22.73M
Operating revenue
-13.48%16.22M
-6.98%16.57M
-24.58%81M
-41.51%17.98M
-20.85%17.99M
-28.66%18.75M
-35.57%17.82M
11.10%107.4M
11.96%30.73M
-6.06%22.73M
Cost of revenue
31.12%5.44M
-3.98%4.59M
-35.20%26.42M
-50.12%6.07M
-36.94%6.3M
-53.87%4.15M
-50.34%4.78M
-8.15%40.77M
-3.47%12.17M
-13.23%9.99M
Gross profit
-26.14%10.79M
-8.08%11.99M
-18.08%54.59M
-35.87%11.91M
-8.24%11.69M
-15.56%14.6M
-27.70%13.04M
27.44%66.63M
25.08%18.56M
0.45%12.74M
Operating expense
-2.56%11.16M
-12.76%12.13M
-27.21%57.48M
-14.73%13.44M
-36.86%13.91M
-46.68%11.46M
-29.36%13.91M
-10.66%78.96M
-28.21%15.76M
-0.50%22.04M
Selling and administrative expenses
-2.96%9.72M
-12.93%10.78M
-29.40%49.47M
-21.33%11.09M
-39.99%11.99M
-46.08%10.02M
-28.91%12.39M
0.28%70.08M
-18.97%14.1M
15.10%19.98M
-Selling and marketing expense
1.03%5.27M
-7.09%5.66M
-34.96%26.96M
-19.68%6.41M
-48.85%6.55M
-50.59%5.22M
-39.71%6.09M
7.06%41.45M
-20.28%7.98M
31.42%12.8M
-General and administrative expense
-7.31%4.45M
-18.59%5.13M
-21.36%22.51M
-23.49%4.68M
-24.17%5.44M
-40.13%4.8M
-14.03%6.3M
-8.14%28.63M
-17.19%6.11M
-5.76%7.18M
Research and development costs
0.19%522K
-28.40%426K
-31.84%2.79M
124.52%1.04M
-27.69%619K
-69.53%521K
-44.08%595K
-67.66%4.1M
-85.71%465K
-73.92%856K
Depreciation amortization depletion
0.33%921K
-0.32%921K
8.86%5.21M
9.04%1.3M
8.76%1.3M
-23.37%918K
-22.81%924K
-18.07%4.79M
-7.94%1.2M
-20.35%1.2M
-Depreciation and amortization
0.33%921K
-0.32%921K
8.86%5.21M
9.04%1.3M
8.76%1.3M
-23.37%918K
-22.81%924K
-18.07%4.79M
-7.94%1.2M
-20.35%1.2M
Operating profit
-112.02%-378K
83.16%-146K
76.57%-2.89M
-154.43%-1.53M
76.11%-2.22M
175.03%3.15M
47.55%-867K
65.85%-12.33M
139.54%2.81M
1.77%-9.29M
Net non-operating interest income expense
14.77%-1.08M
22.53%-994K
3.45%-4.79M
-1.27M
-1.28M
-4.96M
Non-operating interest expense
-14.77%1.08M
-22.53%994K
-3.45%4.79M
----
----
--1.27M
--1.28M
--4.96M
----
----
Other net income (expense)
482.33%1.84M
149.56%2.64M
-2,753.53%-6.4M
891.75%2.4M
-120.17%-422K
80.76%-481K
-659.14%-5.32M
100.33%241K
96.63%-303K
104.77%2.09M
Gain on sale of security
622.70%3.02M
148.76%2.88M
-183.54%-4M
206.48%1.46M
-60.47%1.02M
-141.13%-577K
-369.60%-5.91M
198.63%4.79M
-185.24%-1.37M
36,857.14%2.57M
Special income (charges)
---1.32M
---784K
37.52%-2.96M
-2.84%-2.72M
-133.24%-244K
--0
--0
93.57%-4.74M
73.17%-2.64M
101.67%734K
-Less：Restructuring and merger&acquisition
--1.32M
--784K
344.07%2.37M
556.13%2.12M
133.24%244K
--0
--0
41.45%-969K
52.01%-465K
38.94%-734K
-Less:Impairment of capital assets
----
----
----
----
--0
----
----
----
----
--0
-Less:Other special charges
----
----
--594K
----
----
----
----
----
----
----
-Write off
----
----
--0
----
----
----
----
-40.92%5.71M
----
----
Other non- operating income (expenses)
45.83%140K
-7.19%542K
208.70%568K
-1.62%3.65M
1.65%-1.2M
107.82%96K
153.87%584K
124.31%184K
--3.71M
---1.22M
Income before tax
-72.69%382K
120.05%1.5M
17.45%-14.08M
-59.63%-3.92M
63.31%-2.64M
120.90%1.4M
-966.05%-7.47M
84.34%-17.05M
84.73%-2.46M
86.49%-7.2M
Income tax
-136.28%-283K
405K
1.77M
695K
245K
780K
0
0
0
0
Net income
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
Net income continuous Operations
7.43%665K
114.63%1.09M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
109.25%619K
-966.05%-7.47M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
Net income discontinuous operations
114.66%123K
158.89%381K
----
----
----
---839K
---647K
----
----
----
Minority interest income
Net income attributable to the parent company
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
Basic earnings per share
425.00%0.13
116.22%0.24
44.03%-2.86
-38.98%-0.82
73.06%-0.52
98.14%-0.04
-428.57%-1.48
93.10%-5.11
93.98%-0.59
94.62%-1.93
Diluted earnings per share
-550.00%-0.26
89.86%-0.15
44.03%-2.86
-38.98%-0.82
73.06%-0.52
98.14%-0.04
-428.57%-1.48
93.10%-5.11
93.98%-0.59
94.62%-1.93
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue -13.48%16.22M-6.98%16.57M-24.58%81M-41.51%17.98M-20.85%17.99M-28.66%18.75M-35.57%17.82M11.10%107.4M11.96%30.73M-6.06%22.73M
Operating revenue -13.48%16.22M-6.98%16.57M-24.58%81M-41.51%17.98M-20.85%17.99M-28.66%18.75M-35.57%17.82M11.10%107.4M11.96%30.73M-6.06%22.73M
Cost of revenue 31.12%5.44M-3.98%4.59M-35.20%26.42M-50.12%6.07M-36.94%6.3M-53.87%4.15M-50.34%4.78M-8.15%40.77M-3.47%12.17M-13.23%9.99M
Gross profit -26.14%10.79M-8.08%11.99M-18.08%54.59M-35.87%11.91M-8.24%11.69M-15.56%14.6M-27.70%13.04M27.44%66.63M25.08%18.56M0.45%12.74M
Operating expense -2.56%11.16M-12.76%12.13M-27.21%57.48M-14.73%13.44M-36.86%13.91M-46.68%11.46M-29.36%13.91M-10.66%78.96M-28.21%15.76M-0.50%22.04M
Selling and administrative expenses -2.96%9.72M-12.93%10.78M-29.40%49.47M-21.33%11.09M-39.99%11.99M-46.08%10.02M-28.91%12.39M0.28%70.08M-18.97%14.1M15.10%19.98M
-Selling and marketing expense 1.03%5.27M-7.09%5.66M-34.96%26.96M-19.68%6.41M-48.85%6.55M-50.59%5.22M-39.71%6.09M7.06%41.45M-20.28%7.98M31.42%12.8M
-General and administrative expense -7.31%4.45M-18.59%5.13M-21.36%22.51M-23.49%4.68M-24.17%5.44M-40.13%4.8M-14.03%6.3M-8.14%28.63M-17.19%6.11M-5.76%7.18M
Research and development costs 0.19%522K-28.40%426K-31.84%2.79M124.52%1.04M-27.69%619K-69.53%521K-44.08%595K-67.66%4.1M-85.71%465K-73.92%856K
Depreciation amortization depletion 0.33%921K-0.32%921K8.86%5.21M9.04%1.3M8.76%1.3M-23.37%918K-22.81%924K-18.07%4.79M-7.94%1.2M-20.35%1.2M
-Depreciation and amortization 0.33%921K-0.32%921K8.86%5.21M9.04%1.3M8.76%1.3M-23.37%918K-22.81%924K-18.07%4.79M-7.94%1.2M-20.35%1.2M
Operating profit -112.02%-378K83.16%-146K76.57%-2.89M-154.43%-1.53M76.11%-2.22M175.03%3.15M47.55%-867K65.85%-12.33M139.54%2.81M1.77%-9.29M
Net non-operating interest income expense 14.77%-1.08M22.53%-994K3.45%-4.79M-1.27M-1.28M-4.96M
Non-operating interest expense -14.77%1.08M-22.53%994K-3.45%4.79M----------1.27M--1.28M--4.96M--------
Other net income (expense) 482.33%1.84M149.56%2.64M-2,753.53%-6.4M891.75%2.4M-120.17%-422K80.76%-481K-659.14%-5.32M100.33%241K96.63%-303K104.77%2.09M
Gain on sale of security 622.70%3.02M148.76%2.88M-183.54%-4M206.48%1.46M-60.47%1.02M-141.13%-577K-369.60%-5.91M198.63%4.79M-185.24%-1.37M36,857.14%2.57M
Special income (charges) ---1.32M---784K37.52%-2.96M-2.84%-2.72M-133.24%-244K--0--093.57%-4.74M73.17%-2.64M101.67%734K
-Less：Restructuring and merger&acquisition --1.32M--784K344.07%2.37M556.13%2.12M133.24%244K--0--041.45%-969K52.01%-465K38.94%-734K
-Less:Impairment of capital assets ------------------0------------------0
-Less:Other special charges ----------594K----------------------------
-Write off ----------0-----------------40.92%5.71M--------
Other non- operating income (expenses) 45.83%140K-7.19%542K208.70%568K-1.62%3.65M1.65%-1.2M107.82%96K153.87%584K124.31%184K--3.71M---1.22M
Income before tax -72.69%382K120.05%1.5M17.45%-14.08M-59.63%-3.92M63.31%-2.64M120.90%1.4M-966.05%-7.47M84.34%-17.05M84.73%-2.46M86.49%-7.2M
Income tax -136.28%-283K405K1.77M695K245K780K0000
Net income 458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M
Net income continuous Operations 7.43%665K114.63%1.09M7.08%-15.84M-87.91%-4.62M59.90%-2.89M109.25%619K-966.05%-7.47M84.33%-17.05M84.73%-2.46M86.49%-7.2M
Net income discontinuous operations 114.66%123K158.89%381K---------------839K---647K------------
Minority interest income
Net income attributable to the parent company 458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M
Basic earnings per share 425.00%0.13116.22%0.2444.03%-2.86-38.98%-0.8273.06%-0.5298.14%-0.04-428.57%-1.4893.10%-5.1193.98%-0.5994.62%-1.93
Diluted earnings per share -550.00%-0.2689.86%-0.1544.03%-2.86-38.98%-0.8273.06%-0.5298.14%-0.04-428.57%-1.4893.10%-5.1193.98%-0.5994.62%-1.93
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Oracle
ORCL
140.140
Vale SA
VALE
9.600
Toll Brothers
TOL
101.120
4
D.R. Horton
DHI
125.170
5
Lennar Corp
LEN
108.150
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.